跳至主要内容
临床试验/NCT01154738
NCT01154738已完成3 期

Influence of Lidocaine on a Closed-Loop Anesthesia System

Hopital Foch1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2011年1月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
发起方
Hopital Foch
入组人数
82
试验地点
1
主要终点
administered dose of propofol during maintenance of anesthesia

研究概览

简要总结

The objective is to evaluate the sparing effect of Lidocaine on doses of propofol and remifentanil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients ASA 1, 2 or 3 scheduled for a general anesthesia surgical procedure (abdominal surgery, urology, ENT major procedure) lasting between 1 and 3 hours

排除标准

  • age under 18 years
  • simultaneous general and loco-regional anesthesia
  • allergy to NSAID
  • treatment with verapamil, ketamine or gabapentin
  • patients receiving an opioid preoperatively
  • severe hepatic insufficiency
  • contra-indication to lidocaine
  • contra-indication to propofol or to remifentanil
  • history of central nervous system disease
  • patients receiving a psychotropic treatment
  • patients with a pace-maker

研究组 & 干预措施

Lidocaine

Experimental

Patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and Lidocaine

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and a placebo

干预措施: Placebo (Drug)

结局指标

主要结局

administered dose of propofol during maintenance of anesthesia

时间窗: day 1

次要结局

  • delay (measured as minutes) between the end of propofol and remifentanil administration and the recovery from anesthesia(day 1)
  • postoperative morphine requirement(day 1)
  • incidence of postoperative nausea and vomiting(day 1)
  • % of patients with an explicit memorisation of the intraoperative period(second postoperative day)
  • administered dose of propofol during induction of anesthesia(day 1)
  • administered doses of remifentanil during induction and maintenance of anesthesia(day 1)
  • hemodynamic abnormalities requiring treatment(day 1)
  • % of time with a BIS index between 40 and 60(day 1)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验